Treatment Selection in Multi-Arm Multi-Stage Clinical Trials in Parkinson Disease: The Search for the Ideal Neuroprotective Drug
Objective: The Edmond J Safra Accelerating Clinical Trials in Parkinson disease (PD) initiative (EJS ACT-PD) aims to accelerate the identification of disease modifying treatments for…Deep learning applied to retinal OCT images to differentiate Parkinson’s disease patients from healthy controls
Objective: This study aims to investigate the capability of artificial intelligence, more precisely deep convolutional neural networks (CNN), to automatically classify between healthy controls (HC)…It takes a village: An interdisciplinary care model for atypical Parkinsonism
Objective: To describe one interdisciplinary clinic designed to offer comprehensive care to patients with atypical parkinsonism syndromes, and to share the lessons learned which may…Nutritional Status of Patients with Parkinson’s Disease: Report from Indonesian Tertiary Referral Hospital
Objective: This study aimed to describe and determine the prevalence of nutritional status in outpatient Parkinson’s Disease (PD) patients. Background: Parkinson’s disease is the most…Patient Advisory Boards: A Model for Patient Engagement in Parkinson’s Disease Comparative Effectiveness Research
Objective: To build a replicable, sustainable model of patient engagement in Parkinson’s disease (PD) comparative effectiveness research (CER) at academic research centers through patient advisory…The phenomenon of unexpectedly high functional mobility in people with typical Parkinson’s disease. A cross-sectional data analysis.
Objective: To describe the frequency of people with typical Parkinson’s disease (PD) with unexpectedly high functional mobility (a high functional mobility despite the presence of…Challenges in Outcome Measure Selection in Multi-Arm Multi-Stage Clinical Trials in Parkinson Disease
Objective: The Edmond J Safra Accelerating Clinical Trials in Parkinson Disease (PD) initiative (EJS ACT-PD) aims to accelerate the identification of disease modifying treatment for…Clinical Manifestations of Metabolic Syndrome in Parkinson’s Disease – Report from Indonesia Tertiary Referral Hospital
Objective: The study aims to determine the prevalence of metabolic syndrome and related factors in Parkinson's disease (PD). Background: Parkinson's disease is a neurodegenerative disorder,…Involving people with lived experience of Parkinson’s in trial design: the EJS ACT-PD initiative
Objective: To maximally involve people with the lived experience of Parkinson’s in the design of the first multi-arm multi-stage (MAMS) trial for disease modifying therapies…Feasibility of using wearable sensors to monitor activity and sleep patterns in inpatients with delirium and Parkinson’s disease
Objective: To assess the feasibility of using wearable sensors in Parkinson's disease (PD) inpatients with/without delirium and to quantify clinically relevant digital outcomes to facilitate…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 23
- Next Page »